Vitamin D goes through two chemical transformations before it becomes the hormone that actually does things in your body. The version you make in your skin or swallow in a supplement is biologically inert. Your liver modifies it once, your kidneys modify it again, and only then does it become calcitriol, the active hormone that regulates calcium, influences immune function, and controls gene activity in dozens of tissues. This multi-organ relay is tightly controlled by feedback signals that keep calcitriol levels remarkably stable, and understanding how the relay works helps explain why blood tests measure what they do, why obesity affects vitamin D status, and why some rare genetic conditions can’t be fixed with supplements alone.
Starting Material From Skin and Food
Your body can make its own vitamin D, which is unusual for a vitamin. When ultraviolet B light in the 280–320 nanometer range strikes your skin, it hits a cholesterol-related molecule called 7-dehydrocholesterol sitting in the outer layers of skin cells. The UV energy breaks open one of the molecule’s rings, creating a precursor that then rearranges itself into vitamin D3 (cholecalciferol) through a heat-driven process that takes a couple of days.1PubMed Central. Sunlight and Vitamin D: A global perspective for health This isn’t an enzyme-driven reaction. It’s a straightforward photochemical event followed by a slow thermal conversion, which is why a sunburn doesn’t give you more vitamin D than moderate exposure: once the precursor molecules are used up or degraded, additional UV just damages skin.2Molecular Cell. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications – Section: Vitamin D Production
The vitamin D3 produced in skin or consumed from animal-based foods (fatty fish, egg yolks, fortified dairy) isn’t the only form. Vitamin D2 (ergocalciferol), which comes from fungi and some plants exposed to UV light, enters the same metabolic pathway. Both D2 and D3 are fat-soluble, so dietary forms need bile and dietary fat to be absorbed properly. They travel through the lymphatic system packaged alongside fats, eventually reaching the bloodstream.3Oxford Academic. Transporters in vitamin uptake and cellular metabolism: impacts on health and disease Whether made in your skin or absorbed from your gut, the vitamin D that enters circulation is still inactive. It’s a raw material waiting for processing.
The Liver Adds the First Hydroxyl Group
The first activation step happens in the liver. Enzymes there attach a hydroxyl group (an oxygen-hydrogen pair) to the vitamin D molecule at a specific position, producing 25-hydroxyvitamin D, commonly written as 25(OH)D. This is the form your doctor measures in a blood test, because it’s the most abundant circulating form and reflects your overall vitamin D status over the past few weeks.
The liver enzyme most responsible for this step is CYP2R1. While a few other liver enzymes can perform the same reaction, CYP2R1 is dramatically more efficient. Compared to its closest competitor, CYP2R1 converts vitamin D about 26 times faster relative to how tightly it binds the molecule.4PubMed. Metabolism of vitamin D by human microsomal CYP2R1 This step is relatively unregulated, meaning it proceeds in rough proportion to how much vitamin D enters your bloodstream. If you take a large supplement dose, your 25(OH)D levels rise accordingly. That proportional relationship is exactly why 25(OH)D works well as a status marker: it tells clinicians how much raw material your body has to work with.5PubMed Central. Vitamin D metabolism, mechanism of action, and clinical applications
The Kidneys Complete the Activation
The 25(OH)D produced by the liver circulates to the kidneys, where cells in the proximal tubules perform the second and final hydroxylation. The enzyme CYP27B1 (also called 1-alpha-hydroxylase) adds another hydroxyl group, this time at the 1-alpha position, producing 1,25-dihydroxyvitamin D, or calcitriol. This is the fully active hormone.6PubMed Central. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule
Unlike the liver step, this kidney step is tightly controlled. Your body doesn’t just convert all available 25(OH)D into calcitriol. It makes only as much as it needs, adjusting production minute by minute based on hormonal signals. This is a critical distinction: a blood test showing low 25(OH)D tells you the raw supply is low, but it doesn’t directly tell you how much active calcitriol is being produced, because the kidney controls that conversion independently. Calcitriol levels in the blood can be normal even when 25(OH)D is low, at least up to a point, because the kidney compensates by ramping up conversion efficiency.
How Your Body Controls the Final Activation Step
Two major hormonal signals govern how much calcitriol the kidneys produce, one pushing the accelerator and the other hitting the brake.
The accelerator is parathyroid hormone (PTH). When blood calcium drops, the parathyroid glands release PTH, which tells the kidney to make more calcitriol. Calcitriol then boosts calcium absorption from food in the gut and helps pull calcium from bone reserves. Once calcium levels recover, PTH secretion falls, and calcitriol production slows. Calcitriol itself feeds back on the parathyroid glands to suppress PTH secretion, forming a tight loop.7PubMed Central. PTH and Vitamin D This loop is the core reason the vitamin D system exists: maintaining blood calcium within a narrow range that your nerves, muscles, and heart depend on.
The brake is a hormone called FGF23, produced by bone cells. FGF23 does the opposite of PTH at the kidney: it suppresses the CYP27B1 enzyme, reducing calcitriol production. At the same time, FGF23 activates CYP24A1, the enzyme that breaks calcitriol down into inactive waste products.8PubMed Central. FGF23 and Vitamin D Metabolism FGF23 rises when phosphate levels are high or when calcitriol itself is abundant, effectively saying “we have enough active hormone, stop making more and start clearing what’s here.”9PubMed Central. Interactions between FGF23 and vitamin D The interplay between PTH pushing production up and FGF23 pulling it down is what keeps calcitriol in a remarkably stable range despite wide swings in sun exposure or dietary intake.
How the Active Hormone Gets Deactivated
Calcitriol is potent, and your body needs a way to shut it off. The enzyme CYP24A1 (24-hydroxylase) handles this cleanup. It modifies calcitriol through a series of oxidation steps, ultimately converting it into calcitroic acid, a water-soluble waste product that gets excreted.10PubMed. The vitamin D/CYP24A1 story in cancer CYP24A1 also degrades the precursor 25(OH)D, which means the same enzyme can reduce both the raw supply and the finished product. This enzyme is present in virtually every tissue that responds to vitamin D, acting as a local off-switch. In cancer research, CYP24A1 has attracted attention because some tumors overexpress it, potentially shielding cancer cells from calcitriol’s growth-suppressing effects.
Activation Outside the Kidneys
For decades, researchers assumed the kidneys were the only meaningful source of calcitriol. That turned out to be incomplete. Cells throughout the immune system, including macrophages and dendritic cells, express CYP27B1 and can produce calcitriol locally from circulating 25(OH)D.11PubMed. Vitamin D and its analogs in immune system regulation This locally produced calcitriol doesn’t enter the general circulation in large amounts. Instead, it acts on the cell itself and its immediate neighbors, fine-tuning immune responses at the site of infection or inflammation.12PubMed. Vitamin D and inflammation
The regulation of CYP27B1 in these immune cells is different from the kidney. In the kidney, PTH and FGF23 call the shots. In immune cells, local inflammatory signals drive the enzyme’s activity. That means your immune system can ramp up calcitriol production in response to a pathogen even when blood calcium is fine and the kidney isn’t increasing its own output. This local production pathway is one reason researchers have connected vitamin D status with susceptibility to respiratory infections and autoimmune conditions: if 25(OH)D is too low, immune cells don’t have enough raw material for their own local activation.
The placenta is another site of extra-renal activation. Research using perfused human placentas has shown that placental tissue converts 25(OH)D into calcitriol and releases it into the maternal circulation at levels that could meaningfully raise the mother’s overall calcitriol concentrations.13PubMed Central. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit The placenta also produces calcitriol for local use, where it appears to influence gene expression important for placental function itself. This helps explain why maternal vitamin D status has drawn so much interest in obstetric research.
What Carries Vitamin D Through the Blood
Vitamin D metabolites are fat-soluble and can’t just float freely in blood. Most of the circulating 25(OH)D rides on a dedicated carrier called vitamin D binding protein (DBP). A smaller fraction binds to albumin, and only a tiny sliver circulates unbound, or “free.” This matters because different tissues access vitamin D in different ways.
In the kidneys, the whole DBP-25(OH)D complex gets pulled into cells through a receptor, so even tightly bound vitamin D is available for activation. But many other tissues lack this receptor. For those cells, particularly immune cells that perform extra-renal activation, the free fraction of 25(OH)D is what drives local calcitriol production.14PubMed Central. Vitamin D and DBP: the free hormone hypothesis revisited This “free hormone hypothesis” has clinical implications. Genetic variants that produce DBP with different binding strengths are common across populations and can change the ratio of bound to free 25(OH)D without changing total levels. Two people with identical total 25(OH)D on a blood test might have different amounts of free 25(OH)D available to their immune cells. Researchers are still debating whether measuring free 25(OH)D would be a better indicator of functional vitamin D status than the total level currently used in clinical practice.
Why Obesity Makes the Pathway Less Efficient
People with obesity consistently have lower blood levels of 25(OH)D, and the explanation goes beyond diet or sun habits. Vitamin D is fat-soluble, and adipose (fat) tissue absorbs and stores both vitamin D3 and 25(OH)D. In lean individuals, fat tissue takes up vitamin D but also releases it during lipolysis (when fat cells break down stored fat for energy). In insulin-resistant fat cells, this release is blunted. Research comparing adipose tissue from lean and obese individuals found that when stimulated with adrenaline, obese fat tissue released significantly less vitamin D3 and 25(OH)D back into circulation than lean fat tissue did.15The Journal of Clinical Endocrinology & Metabolism. Impaired Release of Vitamin D in Dysfunctional Adipose Tissue: New Cues on Vitamin D Supplementation in Obesity
Insulin-resistant fat cells also showed higher uptake of vitamin D3 but lower conversion to 25(OH)D within the fat tissue itself, suggesting a metabolic block on top of the storage problem. The practical result is that vitamin D gets trapped in dysfunctional fat tissue, reducing the amount available for liver and kidney activation. This is why clinical guidelines often suggest higher supplementation doses for people with obesity. The extra vitamin D isn’t needed because of greater metabolic demand; it’s needed because more of the dose disappears into fat storage.
D2 Versus D3 in the Metabolic Pipeline
Both vitamin D2 and D3 enter the same activation pathway, but they don’t behave identically. The liver converts both forms to their respective 25-hydroxylated versions, and the kidneys can convert both to active hormones. However, pharmacokinetic modeling shows meaningful differences in how the two forms move through the system. Vitamin D3 appears to be converted to 25(OH)D3 through a saturable process, meaning the liver can only handle so much at once. Vitamin D2, by contrast, is converted through a simpler process that doesn’t saturate as readily. More strikingly, 25(OH)D2 is cleared from the blood almost twice as fast as 25(OH)D3.16PubMed. Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics
The faster clearance of 25(OH)D2 means that a single dose of D2 raises blood levels for a shorter time than the same dose of D3. This is one reason many clinicians prefer D3 for supplementation, especially when doses are given weekly or monthly rather than daily. Both forms work, but D3 tends to maintain more stable blood levels over time. The difference isn’t academic: if you’re getting vitamin D2 from a prescription (the high-dose form available by prescription in some countries is often D2), more frequent dosing may be needed to keep levels steady.
When the Pathway Breaks Down Genetically
Rare genetic mutations can disable specific steps in the vitamin D activation pathway, producing severe disease even when vitamin D supply is adequate. Two conditions illustrate this clearly.
The first is caused by mutations in the CYP27B1 gene, which encodes the kidney enzyme responsible for the final activation step. Without functional CYP27B1, the body can’t convert 25(OH)D into calcitriol. Blood tests show plenty of the precursor but virtually no active hormone. The result is severe rickets and low blood calcium appearing in infancy. Because the enzyme is missing, vitamin D supplements alone won’t help. Treatment requires giving calcitriol itself, bypassing the broken step.17PubMed Central. Genetic disorders and defects in vitamin d action
The second condition involves mutations in the vitamin D receptor (VDR), the protein inside cells that calcitriol binds to trigger gene activity. Here, the entire activation pathway works fine, calcitriol is produced normally, but cells can’t respond to it. This condition is even harder to treat. Some patients respond to very high doses of calcitriol (overwhelming partially functional receptors), while others require direct intravenous calcium to manage their disease. Both conditions are autosomal recessive, meaning a child must inherit a defective gene from each parent to be affected.
How Calcitriol Works Inside Cells
Once calcitriol reaches a target cell, it binds to the vitamin D receptor, a protein that functions as a gene switch. The VDR pairs up with another nuclear receptor called RXR (retinoid X receptor), and together they bind to specific stretches of DNA called vitamin D response elements.18JCI Insight. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights – Section: The VDR This binding recruits other proteins that either ramp up or shut down transcription of nearby genes. Genome-wide studies have identified thousands of VDR binding sites across human DNA, affecting genes involved in calcium transport, immune function, cell growth, and more. The sheer number of target genes is why vitamin D has been linked to so many biological processes beyond bone health.
Calcitriol also triggers some effects that are too fast to involve gene transcription. These rapid, “nongenomic” responses include changes in calcium flow across cell membranes and activation of signaling cascades within seconds to minutes of calcitriol arriving. A membrane-associated protein called PDIA3 has been identified as a receptor responsible for at least some of these quick responses.19PubMed Central. Nongenomic Activities of Vitamin D The nongenomic pathway is less well understood than the gene-regulation pathway, but it appears to be important in muscle cells, intestinal cells, and certain immune cells where rapid calcium signaling matters.
An Ancient System
The vitamin D endocrine system is not a recent evolutionary innovation. The VDR, the activating enzymes, and dedicated transport proteins appear to have been established roughly 550 million years ago in early animals.20PubMed Central. Vitamin D in the Context of Evolution Vitamin D3 itself can be produced by simple photochemistry in any organism with the right cholesterol precursor in its skin, but that reaction predates the endocrine system by a long stretch. In the earliest life forms, the photochemical products were essentially metabolic dead ends with no receptor to bind. A full system with enzymes, a receptor, and hormonal regulation only appears in vertebrates. In the earliest vertebrates like lampreys, the VDR may have originated from the duplication of a gene involved in detoxifying foreign chemicals, later repurposed for calcium regulation as vertebrates evolved mineralized skeletons.21PubMed Central. Vitamin D: calcium and bone homeostasis during evolution The deep evolutionary roots of this pathway help explain why it’s so thoroughly integrated into human physiology. A system that has been managing calcium for half a billion years has had time to become woven into immune regulation, cell proliferation, and other processes far beyond simple mineral balance.